Hepatitis C in the Eastern Mediterranean Region

Eastern Mediterranean Health Journal

Volumn 19, Issue 7, 2013, Pages 587-588

  Esmat, Gamal ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PEGINTERFERON; RIBAVIRIN;

DISEASE MARKER; DISEASE TRANSMISSION; EDITORIAL; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE COST; HEALTH PROGRAM; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; RISK FACTOR; TREATMENT RESPONSE;

CARCINOMA, HEPATOCELLULAR; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MEDITERRANEAN REGION; PREVALENCE;

EID: 84881057531     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.7.587     Document Type: Editorial

References (13)

1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. International Journal of Medical Sciences, 2006, 3:41-46.
2. WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. Journal of Viral Hepatitis, 1999, 6:35-47.
3. The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. Technical paper presented at the 56th Regional Committee for the Eastern Mediterranean, August 2009 (http://applications.emro.who.int/docs/EM_ RC56_3_en.pdf, accessed 20 July 2013).
4. Fallahian F, Najafi A. Epidemiology of Hepatitis C in the Middle East. Saudi Journal of Kidney Diseases and Transplantation, 2011, 22(1):1-9.
5. El-Zanaty, F, Way A. Egypt Demographic and Health Survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International, 2009 (http://www.measuredhs.com/pubs/pdf/FR220/FR220.pdf, accessed 10 July 2011).
6. Mohamed MK et al. HCV-related morbidity in a rural community of Egypt. Journal of Medical Virology, 2006, 78:1185-1189.
7. Nguyen MH, Keeffe EB. Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Reviews in Gastroenterological Disorders, 2004, 4(Suppl. 1):S14-S21.
8. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. International Journal of Infectious Diseases, 2006, 10:272-277.
9. Sievert W et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver International, 2011, 31(Suppl. 2):61-80.
10. Bdour S. Hepatitis C virus infection in Jordanian hemodialysis units: serological diagnosis and genotyping. Journal of Medical Microbiology, 2002, 51(8):700-704.
11. Shemer-Avni Y et al. Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. Journal of Medical Virology, 1998, 56:230-233.
12. Esmat G et al. The future for the treatment of genotype 4 chronic hepatitis C. Liver International, 2012, 32(Suppl. 1):146-150.
13. Progress toward prevention and control of hepatitis C virus infection Egypt, 2001-2012. MMWR. Morbidity and Mortality Weekly Report, 2012, 61(29):545-549.